Publication: Application of microneedle patches for drug delivery; doorstep to novel therapies
dc.contributor.coauthor | Nazary Abrbekoh, F. | |
dc.contributor.coauthor | Salimi, L. | |
dc.contributor.coauthor | Saghati, S. | |
dc.contributor.coauthor | Amini, H. | |
dc.contributor.coauthor | Fathi Karkan, S. | |
dc.contributor.coauthor | Moharamzadeh, K. | |
dc.contributor.coauthor | Rahbarghazi R. | |
dc.contributor.kuauthor | Sokullu, Emel | |
dc.contributor.kuprofile | Faculty Member | |
dc.contributor.researchcenter | Koç University Research Center for Translational Medicine (KUTTAM) / Koç Üniversitesi Translasyonel Tıp Araştırma Merkezi (KUTTAM) | |
dc.contributor.schoolcollegeinstitute | School of Medicine | |
dc.contributor.yokid | 163024 | |
dc.date.accessioned | 2024-11-09T12:16:34Z | |
dc.date.issued | 2022 | |
dc.description.abstract | In the past decade, microneedle-based drug delivery systems showed promising approaches to become suitable and alternative for hypodermic injections and can control agent delivery without side effects compared to conventional approaches. Despite these advantages, the procedure of microfabrication is facing some difficulties. For instance, drug loading method, stability of drugs, and retention time are subjects of debate. Besides, the application of novel refining fabrication methods, types of materials, and instruments are other issues that need further attention. Herein, we tried to summarize recent achievements in controllable drug delivery systems (microneedle patches) in vitro and in vivo settings. In addition, we discussed the influence of delivered drugs on the cellular mechanism and immunization molecular signaling pathways through the intradermal delivery route. Understanding the putative efficiency of microneedle patches in human medicine can help us develop and design sophisticated therapeutic modalities. | |
dc.description.fulltext | YES | |
dc.description.indexedby | WoS | |
dc.description.indexedby | Scopus | |
dc.description.indexedby | PubMed | |
dc.description.openaccess | YES | |
dc.description.publisherscope | International | |
dc.description.sponsoredbyTubitakEu | N/A | |
dc.description.sponsorship | N/A | |
dc.description.version | Publisher version | |
dc.description.volume | 13 | |
dc.format | ||
dc.identifier.doi | 10.1177/20417314221085390 | |
dc.identifier.embargo | NO | |
dc.identifier.filenameinventoryno | IR03618 | |
dc.identifier.issn | 2041-7314 | |
dc.identifier.link | https://doi.org/10.1177/20417314221085390 | |
dc.identifier.quartile | N/A | |
dc.identifier.scopus | 2-s2.0-85129202650 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/1390 | |
dc.identifier.wos | 333538100009 | |
dc.keywords | Delivery system | |
dc.keywords | Diabetes | |
dc.keywords | Drugs | |
dc.keywords | Microneedle patches | |
dc.keywords | Transdermal injection | |
dc.language | English | |
dc.publisher | Sage | |
dc.relation.grantno | NA | |
dc.relation.uri | http://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/10476 | |
dc.source | Journal of Tissue Engineering | |
dc.subject | Cell biology | |
dc.title | Application of microneedle patches for drug delivery; doorstep to novel therapies | |
dc.type | Review | |
dspace.entity.type | Publication | |
local.contributor.authorid | 0000-0003-1302-1997 | |
local.contributor.kuauthor | Sokullu, Emel |
Files
Original bundle
1 - 1 of 1